Maria Ekblad
Chief Tech/Sci/R&D Officer bij FOLLICUM AB (PUBL)
Profiel
Maria Ekblad is currently working as the Chief Operating Officer at Aptahem AB since 2022.
Prior to this, she worked as the Director of Research and Development at Follicum AB since 2016.
Ms. Ekblad has a graduate degree from the University of Lund.
Actieve functies van Maria Ekblad
| Bedrijven | Functie | Begin |
|---|---|---|
| FOLLICUM AB (PUBL) | Chief Tech/Sci/R&D Officer | 01-01-2016 |
Aptahem AB
 Aptahem AB Pharmaceuticals: MajorHealth Technology Aptahem AB operates as a biotechnology company. The firm engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded byLuiza Jedlina, Bert Junno, Tina Persson and Johan Lindh in 2014 and is headquartered in Malmo, Sweden. | Chief Operating Officer | 14-01-2022 |
Opleiding van Maria Ekblad
| University of Lund | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
 | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Follicum AB
 Follicum AB Pharmaceuticals: MajorHealth Technology Follicum AB is a biotech company, which engages in discovery and development of peptide-based drugs. Its product pipeline include FOL-005, FOL-00X, FOL-014, and FOL-00Y which is made for stimulation of hair growth and treatment of diabetes. The company was founded by Anna Kerstin Emy Hultgårdh Nilsson and Claes Pontus Dunér on May 3, 2011 and is headquartered in Lund, Sweden. | Health Technology |
